Showing results (721-730 of 1,286) with videos related to

Sort By:
Pageof 129
Diabetes, Obesity & Metabolism|July 2, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O TrialDaniel Raaschou-Oddershede, Christine R Schwarz, Tanya Kovalova, et al.
Trials|July 17, 2020
Correction to: Protocol for a randomised controlled trial to investigate the effect of home- and gym-based resistance exercise training on glycaemic control, body composition and muscle strengthEbaa Al Ozairi, Dalal Alsaeed, Dennis Taliping, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 9, 2022
Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetesMariam Elmegaard Malik, Charlotte Andersson, Paul Blanche, et al.
Diabetes|April 16, 2010
A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam StudySjoerd M Euser, Naveed Sattar, Jacqueline C M Witteman, et al.
The Lancet Regional Health. Europe|December 16, 2025
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort studyLaura M Güdemann, Katherine G Young, Pedro Cardoso, et al.
The Journal of Applied Laboratory Medicine|July 7, 2022
The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating LevelsYanislava Karusheva, Matthew Ratcliff, Alexander Mörseburg, et al.
Proteomics. Clinical Applications|March 20, 2015
Urinary proteomic biomarkers to predict cardiovascular eventsCatriona E Brown, Nina S McCarthy, Alun D Hughes, et al.
Diabetes Research and Clinical Practice|March 28, 2024
Ongoing burden and recent trends in severe hospitalised hypoglycaemia events in people with type 1 and type 2 diabetes in Scotland: A nationwide cohort study 2016-2022William Berthon, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
Diabetes Care|June 18, 2026
To Cluster or Not to Cluster? A Comparison of Approaches to Targeting Type 2 Diabetes Glucose-Lowering Therapy in the TriMaster Crossover TrialLaura M Güdemann, Catherine Angwin, Rury R Holman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 18, 2020
Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysisMatthew M Y Lee, Kieran F Docherty, Naveed Sattar, et al.
Pageof 129